Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
Hemoglobin Levels
Factors Contributing to Ribavirin-induced Anemia
- 10/22/04
Sex, Magnitude of
Hemoglobin
Decline and Renal Function Are Potentially Important Factors to Consider in Patients Receiving Ribavirin
- 08/13/04
Evaluating Epoetin Alfa 40,000 U SC Every 2 Weeks to Maintain
Hemoglobin
Levels in Anemic HIV Patients
- 09/26/03
Procrit (epoetin alfa) Treatment of Anemic HCV Patients Allows for Maintenance of Ribavirin Dose, Increases
Hemoglobin
Levels, and Improves Quality of Life
- 05/21/03
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
